Amar Remedies Key Ratios

NSE: AMAR | BSE: 532664

₹6.07

up-down-arrow0.03 (0.50%)

As on 11-Dec-2013IST

Market cap

info icon

₹16 Cr

Revenue (TTM)

info icon

₹492 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -65.53 -75.07 -27.10 1.34 10.51
EBIT -331.69 -130.53 -79.10 -28.78 -8.90
Net Profit -78.80 -382.57 -193.78 -209.57 -214.28
EPS -78.80 -382.58 -193.78 -209.57 -214.28
Book Value -- -- 21.51 20.57 20.67
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMJun-12Jun-11
EBIT-Margin info 13.1412.314.2614.6612.11
Net Margin info 6.696.91-8.636.636.55
Return on equity info 19.5519.56--19.1619.98
Return on Capital info 19.4919.80--17.6419.16
Return on Assets info 8.859.63-7.177.729.11
Debt to Equity (x) info ----0.191.461.17
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
--
17.66
18.93
21.88
20.38
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
--
19.22
19.54
19.89
19.73
Peer Median
21.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-7.17

Lower than Peers by 21.72

Profit after tax / Average Total assets * 100

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
-7.17
7.71
8.93
9.92
10.65
Peer Median
14.55
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

4.26

Lower than Peers by 13.59

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
4.26
14.84
12.33
12.26
10.94
Peer Median
17.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-8.63

Lower than Peers by 23.53

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
-8.63
6.69
6.57
6.82
7.19
Peer Median
14.90
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
--
8.55
8.45
9.00
9.16
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

-27.10

Lower than Peers by 31.75

Year on year growth in net sales

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
-27.10
16.67
22.36
27.97
23.79
Peer Median
4.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-79.10

Lower than Peers by 82.99

Year on year growth in operating profit (EBIT)

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
-79.10
40.44
23.06
43.31
21.21
Peer Median
3.90
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-193.78

Lower than Peers by 197.61

Year on year growth in profit after tax

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
-193.78
18.88
17.99
20.87
22.60
Peer Median
3.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-193.78

Lower than Peers by 196.69

Year on year growth in earnings per share

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
-193.78
18.88
17.99
20.87
22.60
Peer Median
2.91
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
--
21.51
20.06
20.16
19.58
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

0.19

--

Total debt / Net worth

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
0.19
1.47
1.18
0.70
0.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

1.27

--

(Short term borrowings / Net worth)

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
1.27
1.21
1.03
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.37

Lower than Peers by 0.32

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
1.37
1.33
1.34
4.28
3.70
Peer Median
1.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.78

Lower than Peers by 0.56

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
0.78
0.68
0.72
2.28
2.02
Peer Median
1.34
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

0.21

Lower than Peers by 38.46

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
0.21
2.44
2.63
2.83
3.40
Peer Median
38.67
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

41.81

Higher than Peers by 34.36

Debtors outstanding / Net Sales * 100

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
41.81
27.33
24.12
22.87
22.30
Peer Median
7.45
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.83

Lower than Peers by 0.09

Sales / Average Total Assets

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
0.83
1.16
1.36
1.45
1.47
Peer Median
0.92
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
--
87.03
77.68
73.53
74.30
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
--
103.53
83.48
74.97
63.89
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
--
10.35
8.98
12.58
10.86
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
--
180.20
152.19
135.92
127.33
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
--
7.80
6.99
6.26
2.76
Peer Median
33.27
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.07

Lower than Peers by 7.07

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
0.07
1.37
1.25
1.14
0.50
Peer Median
7.15
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
--
--
0.98
1.30
3.55
Peer Median
2.04
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

10.59

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
10.59
6.29
6.05
4.68
3.26
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

16

Lower than Peers by 26,293

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Jun-12
Jun-11
Jun-10
Jun-09
Amar Remedies
16
353
266
202
74
Peer Median
26,308
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...